Get started
Author

David A. Eichenbaum

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
2023 · Arshad M Khanani, Arshad M Khanani, et al. · The Lancet · 366
PDF
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial
2024 · Paolo Lanzetta, Jean-François Korobelnik, et al. · The Lancet · 266
TENAYA and LUCERNE
2024 · Arshad M. Khanani, Aachal Kotecha, et al. · Ophthalmology · 227
Faricimab Treat-and-Extend for Diabetic Macular Edema
2023 · Tien Y. Wong, Zdenka Haskova, et al. · Ophthalmology · 177
PDF
Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial
2023 · Sunil S. Patel, David R. Lally, et al. · Eye · 143
PDF
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial
2024 · David M Brown, David S Boyer, et al. · The Lancet · 135
PDF
Current and upcoming anti-VEGF therapies and dosing strategies for the treatment of neovascular AMD: a comparative review
2019 · Saira Khanna, Rahul Komati, et al. · BMJ Open Ophthalmology · 124
Ranibizumab Induces Regression of Diabetic Retinopathy in Most Patients at High Risk of Progression to Proliferative Diabetic Retinopathy
2018 · Charles C. Wykoff, David A. Eichenbaum, et al. · Ophthalmology Retina · 94
PDF
Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration
2021 · Ana Bety Enríquez, Caroline R. Baumal, et al. · JAMA Ophthalmology · 76
PDF
Angiopoietins as Potential Targets in Management of Retinal Disease
2021 · Arshad M Khanani, Matthew W Russell, et al. · Clinical ophthalmology · 64
PDF
Optimal Management of Pigment Epithelial Detachments in Eyes With Neovascular Age-related Macular Degeneration
2018 · Arshad M. Khanani, David Eichenbaum, et al. · Retina · 61
Efficacy and Safety of Brolucizumab for Diabetic Macular Edema
2023 · Rishi P. Singh, Mark R. Barakat, et al. · JAMA Ophthalmology · 42
PDF
Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALITII)
2022 · Rui Wang, Cynthia K McClard, et al. · BMJ Open Ophthalmology · 41
PDF
Intravitreal Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration
2025 · Jean-François Korobelnik, Paolo Lanzetta, et al. · Ophthalmology · 39
Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN study
2020 · Sam E Mansour, Daniel F Kiernan, et al. · British Journal of Ophthalmology · 33
PDF
Home Monitoring of Age-Related Macular Degeneration
2020 · Hannah J. Yu, Daniel F. Kiernan, et al. · Ophthalmology Retina · 31
Real-World Performance of a Self-Operated Home Monitoring System for Early Detection of Neovascular Age-Related Macular Degeneration
2021 · Allen C. Ho, Jeffrey S. Heier, et al. · Journal of Clinical Medicine · 30
PDF
Biosimilars for retinal diseases: United States-Europe awareness survey (Bio-USER – survey)
2023 · Ashish Sharma, Frank G Holz, et al. · Expert Opinion on Biological Therapy · 28
PDF
Inhibition of Complement Factor 3 in Geographic Atrophy with NGM621: Phase 1 Dose-Escalation Study Results
2021 · Charles C. Wykoff, Vrinda Hershberger, et al. · American Journal of Ophthalmology · 27
Randomized Phase IIb Study of Brimonidine Drug Delivery System Generation 2 for Geographic Atrophy in Age-Related Macular Degeneration
2023 · William R. Freeman, Francesco Bandello, et al. · Ophthalmology Retina · 25
Geographic atrophy: clinical impact and emerging treatments
2015 · Hershel R. Patel, David Eichenbaum · Ophthalmic surgery, lasers & imaging retina · 25
Evolving Guidelines for Intracameral Injection
2020 · Jeffrey M. Liebmann, Keith Barton, et al. · Journal of Glaucoma · 23
Real-world efficacy and safety of 8 mg aflibercept in neovascular AMD: a case series
2025 · Deepak Sambhara, Priya Vakharia, et al. · BMJ Open Ophthalmology · 22
PDF
Vascular Endothelial Growth Factor C and D Signaling Pathways as Potential Targets for the Treatment of Neovascular Age-Related Macular Degeneration: A Narrative Review
2024 · Ian M. Leitch, Michael Gerometta, et al. · Ophthalmology and Therapy · 22
Phase I DAVIO Trial: EYP-1901 Bioerodible, Sustained-Delivery Vorolanib Insert in Patients With Wet Age-Related Macular Degeneration
2024 · Sunil Patel, Philip P. Storey, et al. · Ophthalmology Science · 22
Works count: 99
Citation count: 2,462
H-index: 22
I10-index: 39
Year
Topic
Type